AUG 4, 2026 · PHASE 2 TRIAL
Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer
ClinicalTrials.gov
This is an active Phase 2 trial registration with no results posted; the study design and rationale are described but no efficacy or safety outcomes are reported.
Reported
Planned enrollment117
PhasePhase 2
Primary outcome measureProgression-free survival (PFS), assessed a…